Yang, J., Mo, J., Dai, J., Ye, C., Cen, W., Zheng, X., . . . Ye, L. (2021). Cetuximab promotes RSL3-induced ferroptosis by suppressing the Nrf2/HO-1 signalling pathway in KRAS mutant colorectal cancer. Nature Publishing Group.
Cita Chicago Style (17a ed.)Yang, Jiawen, Jiajie Mo, Juji Dai, Chenqiao Ye, Wei Cen, Xuzhi Zheng, Lei Jiang, y Lechi Ye. Cetuximab Promotes RSL3-induced Ferroptosis by Suppressing the Nrf2/HO-1 Signalling Pathway in KRAS Mutant Colorectal Cancer. Nature Publishing Group, 2021.
Cita MLA (8a ed.)Yang, Jiawen, et al. Cetuximab Promotes RSL3-induced Ferroptosis by Suppressing the Nrf2/HO-1 Signalling Pathway in KRAS Mutant Colorectal Cancer. Nature Publishing Group, 2021.
Precaución: Estas citas no son 100% exactas.